Blog | Oncotarget

ICBs and MEKi Improves Efficacy of Anti-Tumor Antibodies in Melanoma

Researchers from Columbia University demonstrate that, in mouse-model melanoma, the therapeutic efficacy of unmodified anti-tumor... read more

By Kathryn Atkins January 19, 2021

Scientists discuss their findings in a recently published paper in Oncotarget entitled, "ONC201 kills breast... read more

By Oncotarget January 18, 2021

The current study is the first of its kind, wherein comprehensive transcriptome analysis using RNA-Seq... read more

By Kathryn Atkins January 14, 2021

Researchers describe their paper published in Oncotarget titled, "Secretomes from metastatic breast cancer cells, enriched... read more

By Oncotarget January 11, 2021

Researchers perform a phase three subgroup analysis study demonstrating positive results in patients with HPV-negative... read more

By Kathryn Atkins January 7, 2021

Read short summaries every other week on the latest oncology focused peer-reviewed literature published by... read more

By Oncotarget January 6, 2021

Researchers in this study use scaling analysis to show that, in patients with prostate cancer... read more

By Kathryn Atkins January 5, 2021

Researchers discuss their paper published in Oncotarget, entitled: "Down syndrome induced pluripotent stem cell model... read more

By Oncotarget January 4, 2021

Read short summaries every other week on the latest oncology focused peer-reviewed literature published by... read more

By Oncotarget December 31, 2020

This review compiles splice variations in HER2 breast cancer, specifically in the context of the... read more

By Kathryn Atkins December 31, 2020